Avacta Group plc announced the appointment of Paul Fry as Non Executive Director with effect from 3 February 2020. He is currently Chief Financial Officer of Vectura Group plc, an industry leading inhaled drug delivery specialist listed on the FTSE Main Market. Paul will be appointed Chair of the Audit Committee.